NORWALK, Conn. & SEATTLE-- --The Multiple Myeloma Research Foundation , in collaboration with the University of Torino and Adaptive Biotechnologies, today announced a collaboration to perform sequencing-based assessment of minimal residual disease on hundreds of multiple myeloma patients over a five year period.
via Norwalk Newswire http://www.biospace.com/news_story.aspx?StoryID=372240&full=1
via Norwalk Newswire http://www.biospace.com/news_story.aspx?StoryID=372240&full=1
No comments:
Post a Comment